$FLXN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Flexion Therapeutics Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Flexion Therapeutics Inc. Get notifications about new insider transactions in Flexion Therapeutics Inc for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28 2021 | FLXN | Flexion Therapeuti ... | Kwo Elizabeth | Director | Option Exercise | A | 9.22 | 7,000 | 64,540 | 7,000 | |
| Jun 28 2021 | FLXN | Flexion Therapeuti ... | Kwo Elizabeth | Director | Grant | A | 0.00 | 4,500 | 0 | 4,500 | 0 to 4.5 K |
| May 12 2021 | FLXN | Flexion Therapeuti ... | Arkowitz David | Chief Financial Off ... | Sell | S | 7.23 | 2,229 | 16,116 | 220,719 | 222.9 K to 220.7 K (-1.00 %) |
| Mar 23 2021 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Gift | G | 0.00 | 21,099 | 0 | 347,140 | 368.2 K to 347.1 K (-5.73 %) |
| Mar 23 2021 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Gift | G | 0.00 | 4,762 | 0 | 368,239 | 373 K to 368.2 K (-1.28 %) |
| Mar 16 2021 | FLXN | Flexion Therapeuti ... | Layman Melissa | Chief Commercial Of ... | Sell | S | 11.80 | 4,520 | 53,336 | 103,956 | 108.5 K to 104 K (-4.17 %) |
| Jan 29 2021 | FLXN | Flexion Therapeuti ... | Layman Melissa | Chief Commercial Of ... | Sell | S | 12.55 | 2,624 | 32,931 | 88,376 | 91 K to 88.4 K (-2.88 %) |
| Jan 29 2021 | FLXN | Flexion Therapeuti ... | Layman Melissa | Chief Commercial Of ... | Grant | A | 0.00 | 30,000 | 0 | 91,000 | 61 K to 91 K (+49.18 %) |
| Jan 29 2021 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Payment of Exercise | F | 12.37 | 8,776 | 108,559 | 266,901 | 275.7 K to 266.9 K (-3.18 %) |
| Jan 29 2021 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Grant | A | 0.00 | 119,500 | 0 | 275,677 | 156.2 K to 275.7 K (+76.52 %) |
| Jan 20 2021 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Buy | J | 0.00 | 943 | 0 | 943 | 0 to 943 |
| Jan 20 2021 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Buy | J | 0.00 | 2,198 | 0 | 47,531 | 45.3 K to 47.5 K (+4.85 %) |
| Jan 20 2021 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Sell | J | 0.00 | 14,868 | 0 | 5,871 | 20.7 K to 5.9 K (-71.69 %) |
| Jan 20 2021 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Buy | J | 0.00 | 19,653 | 0 | 19,653 | 0 to 19.7 K |
| Jan 20 2021 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Sell | J | 0.00 | 648,266 | 0 | 0 | 648.3 K to 0 (-100.00 %) |
| Jan 20 2021 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Buy | J | 0.00 | 648,266 | 0 | 648,266 | 0 to 648.3 K |
| Jan 20 2021 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Sell | J | 0.00 | 2,517,541 | 0 | 994,129 | 3.5 M to 994.1 K (-71.69 %) |
| Jan 07 2021 | FLXN | Flexion Therapeuti ... | Muzikant Adam | Chief Business Offi ... | Sell | S | 11.13 | 4,005 | 44,576 | 73,455 | 77.5 K to 73.5 K (-5.17 %) |
| Jan 07 2021 | FLXN | Flexion Therapeuti ... | KELLEY SCOTT | Chief Medical Offic ... | Sell | S | 11.13 | 6,829 | 76,007 | 113,549 | 120.4 K to 113.5 K (-5.67 %) |
| Jan 07 2021 | FLXN | Flexion Therapeuti ... | Wentworth Kerry | Chief Regulatory Of ... | Sell | S | 11.13 | 6,829 | 76,007 | 113,767 | 120.6 K to 113.8 K (-5.66 %) |
| Jan 07 2021 | FLXN | Flexion Therapeuti ... | Willwerth Christina | Chief Strategy Offi ... | Sell | S | 11.13 | 6,602 | 73,480 | 115,186 | 121.8 K to 115.2 K (-5.42 %) |
| Jan 07 2021 | FLXN | Flexion Therapeuti ... | Levine Mark S. | General Counsel | Sell | S | 11.13 | 6,829 | 76,007 | 107,431 | 114.3 K to 107.4 K (-5.98 %) |
| Jan 07 2021 | FLXN | Flexion Therapeuti ... | Arkowitz David | Chief Financial Off ... | Sell | S | 11.13 | 6,073 | 67,592 | 151,048 | 157.1 K to 151 K (-3.87 %) |
| Jan 07 2021 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Payment of Exercise | F | 0.00 | 2,530 | 0 | 156,177 | 158.7 K to 156.2 K (-1.59 %) |
| Jan 07 2021 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Gift | G | 0.00 | 1,303 | 0 | 158,707 | 160 K to 158.7 K (-0.81 %) |
| Aug 20 2020 | FLXN | Flexion Therapeuti ... | Kwo Elizabeth | Director | Option Exercise | A | 12.54 | 32,000 | 401,280 | 32,000 | |
| Jul 20 2020 | FLXN | Flexion Therapeuti ... | Arkowitz David | Chief Financial Off ... | Grant | A | 0.00 | 38,750 | 0 | 157,121 | 118.4 K to 157.1 K (+32.74 %) |
| Jul 20 2020 | FLXN | Flexion Therapeuti ... | KELLEY SCOTT | Chief Medical Offic ... | Grant | A | 0.00 | 38,750 | 0 | 119,710 | 81 K to 119.7 K (+47.86 %) |
| Jul 20 2020 | FLXN | Flexion Therapeuti ... | Arkowitz David | Chief Financial Off ... | Grant | A | 0.00 | 38,750 | 0 | 157,121 | 118.4 K to 157.1 K (+32.74 %) |
| Jul 20 2020 | FLXN | Flexion Therapeuti ... | Willwerth Christina | Chief Strategy Offi ... | Grant | A | 0.00 | 38,750 | 0 | 121,788 | 83 K to 121.8 K (+46.67 %) |
| Jul 20 2020 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Grant | A | 0.00 | 93,750 | 0 | 160,010 | 66.3 K to 160 K (+141.49 %) |
| Jul 20 2020 | FLXN | Flexion Therapeuti ... | KELLEY SCOTT | Chief Medical Offic ... | Grant | A | 0.00 | 38,750 | 0 | 119,710 | 81 K to 119.7 K (+47.86 %) |
| Jul 20 2020 | FLXN | Flexion Therapeuti ... | Levine Mark S. | General Counsel | Grant | A | 0.00 | 38,750 | 0 | 114,260 | 75.5 K to 114.3 K (+51.32 %) |
| Jul 20 2020 | FLXN | Flexion Therapeuti ... | Wentworth Kerry | Chief Regulatory Of ... | Grant | A | 0.00 | 38,750 | 0 | 120,180 | 81.4 K to 120.2 K (+47.59 %) |
| Jul 20 2020 | FLXN | Flexion Therapeuti ... | Willwerth Christina | Chief Strategy Offi ... | Grant | A | 0.00 | 38,750 | 0 | 121,788 | 83 K to 121.8 K (+46.67 %) |
| Jul 20 2020 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Grant | A | 0.00 | 93,750 | 0 | 160,010 | 66.3 K to 160 K (+141.49 %) |
| Jul 20 2020 | FLXN | Flexion Therapeuti ... | Levine Mark S. | General Counsel | Grant | A | 0.00 | 38,750 | 0 | 114,260 | 75.5 K to 114.3 K (+51.32 %) |
| Jul 20 2020 | FLXN | Flexion Therapeuti ... | Wentworth Kerry | Chief Regulatory Of ... | Grant | A | 0.00 | 38,750 | 0 | 120,180 | 81.4 K to 120.2 K (+47.59 %) |
| Jul 10 2020 | FLXN | Flexion Therapeuti ... | MILINAZZO ALAN | Director | Option Exercise | M | 2.20 | 18,450 | 40,500 | 0 | |
| Jul 10 2020 | FLXN | Flexion Therapeuti ... | MILINAZZO ALAN | Director | Buy | M | 2.20 | 18,450 | 40,500 | 22,950 | 4.5 K to 23 K (+410.00 %) |
| Jun 24 2020 | FLXN | Flexion Therapeuti ... | Willwerth Christina | Chief Strategy Offi ... | Sell | J | 0.00 | 435 | 0 | 83,038 | 83.5 K to 83 K (-0.52 %) |
| Jun 24 2020 | FLXN | Flexion Therapeuti ... | Arkowitz David | Chief Financial Off ... | Grant | A | 10.83 | 1,303 | 14,111 | 118,371 | 117.1 K to 118.4 K (+1.11 %) |
| Jun 24 2020 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Grant | A | 10.83 | 1,303 | 14,111 | 66,260 | 65 K to 66.3 K (+2.01 %) |
| Jun 24 2020 | FLXN | Flexion Therapeuti ... | KELLEY SCOTT | Chief Medical Offic ... | Grant | A | 10.83 | 595 | 6,444 | 80,960 | 80.4 K to 81 K (+0.74 %) |
| Jun 24 2020 | FLXN | Flexion Therapeuti ... | Levine Mark S. | General Counsel | Grant | A | 10.83 | 1,023 | 11,079 | 75,510 | 74.5 K to 75.5 K (+1.37 %) |
| Jun 24 2020 | FLXN | Flexion Therapeuti ... | Wentworth Kerry | Chief Regulatory Of ... | Grant | A | 10.83 | 369 | 3,996 | 81,430 | 81.1 K to 81.4 K (+0.46 %) |
| Jun 12 2020 | FLXN | Flexion Therapeuti ... | Stejbach Mark | Director | Option Exercise | A | 11.88 | 7,000 | 83,160 | 7,000 | |
| Jun 12 2020 | FLXN | Flexion Therapeuti ... | Stejbach Mark | Director | Grant | A | 0.00 | 4,500 | 0 | 6,551 | 2.1 K to 6.6 K (+219.41 %) |
| Jun 12 2020 | FLXN | Flexion Therapeuti ... | MAHAFFY PATRICK J | Director | Option Exercise | A | 11.88 | 12,500 | 148,500 | 12,500 | |
| Jun 12 2020 | FLXN | Flexion Therapeuti ... | MAHAFFY PATRICK J | Director | Grant | A | 0.00 | 4,500 | 0 | 35,324 | 30.8 K to 35.3 K (+14.60 %) |
| Jun 12 2020 | FLXN | Flexion Therapeuti ... | MILINAZZO ALAN | Director | Option Exercise | A | 11.88 | 7,000 | 83,160 | 7,000 | |
| Jun 12 2020 | FLXN | Flexion Therapeuti ... | MILINAZZO ALAN | Director | Grant | A | 0.00 | 4,500 | 0 | 4,500 | 0 to 4.5 K |
| Jun 12 2020 | FLXN | Flexion Therapeuti ... | MERRIFIELD C ANN | Director | Option Exercise | A | 11.88 | 7,000 | 83,160 | 7,000 | |
| Jun 12 2020 | FLXN | Flexion Therapeuti ... | MERRIFIELD C ANN | Director | Grant | A | 0.00 | 4,500 | 0 | 14,500 | 10 K to 14.5 K (+45.00 %) |
| Jun 12 2020 | FLXN | Flexion Therapeuti ... | Mahatme Sandesh | Director | Option Exercise | A | 11.88 | 7,000 | 83,160 | 7,000 | |
| Jun 12 2020 | FLXN | Flexion Therapeuti ... | Mahatme Sandesh | Director | Grant | A | 0.00 | 4,500 | 0 | 4,500 | 0 to 4.5 K |
| Jun 12 2020 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Option Exercise | A | 11.88 | 7,000 | 83,160 | 7,000 | |
| Jun 12 2020 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Grant | A | 0.00 | 4,500 | 0 | 30,004 | 25.5 K to 30 K (+17.64 %) |
| Jun 12 2020 | FLXN | Flexion Therapeuti ... | Canute Scott A | Director | Option Exercise | A | 11.88 | 7,000 | 83,160 | 7,000 | |
| Jun 12 2020 | FLXN | Flexion Therapeuti ... | Canute Scott A | Director | Grant | A | 0.00 | 4,500 | 0 | 4,500 | 0 to 4.5 K |
| May 27 2020 | FLXN | Flexion Therapeuti ... | Stejbach Mark | Director | Buy | P | 9.75 | 2,051 | 19,997 | 2,051 | 0 to 2.1 K |
| May 27 2020 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Buy | P | 9.75 | 10,256 | 99,996 | 346,605 | 336.3 K to 346.6 K (+3.05 %) |
| May 11 2020 | FLXN | Flexion Therapeuti ... | Arkowitz David | Chief Financial Off ... | Sell | S | 10.88 | 2,413 | 26,253 | 117,068 | 119.5 K to 117.1 K (-2.02 %) |
| Apr 03 2020 | FLXN | Flexion Therapeuti ... | Layman Melissa | Chief Commercial Of ... | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
| Apr 03 2020 | FLXN | Flexion Therapeuti ... | Layman Melissa | Chief Commercial Of ... | Option Exercise | A | 7.01 | 30,000 | 210,300 | 30,000 | |
| Apr 03 2020 | FLXN | Flexion Therapeuti ... | Layman Melissa | Chief Commercial Of ... | Grant | A | 0.00 | 61,000 | 0 | 61,000 | 0 to 61 K |
| Mar 03 2020 | FLXN | Flexion Therapeuti ... | Willwerth Christina | Chief Strategy Offi ... | Option Exercise | A | 15.78 | 15,500 | 244,590 | 15,500 | |
| Mar 03 2020 | FLXN | Flexion Therapeuti ... | Willwerth Christina | Chief Strategy Offi ... | Grant | A | 0.00 | 31,000 | 0 | 83,473 | 52.5 K to 83.5 K (+59.08 %) |
| Mar 03 2020 | FLXN | Flexion Therapeuti ... | Wentworth Kerry | Chief Regulatory Of ... | Option Exercise | A | 15.78 | 15,500 | 244,590 | 15,500 | |
| Mar 03 2020 | FLXN | Flexion Therapeuti ... | Wentworth Kerry | Chief Regulatory Of ... | Grant | A | 0.00 | 31,000 | 0 | 81,061 | 50.1 K to 81.1 K (+61.92 %) |
| Jan 07 2020 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Gift | G | 0.00 | 5,457 | 0 | 336,349 | 341.8 K to 336.3 K (-1.60 %) |
| Jan 07 2020 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Gift | G | 0.00 | 10,398 | 0 | 330,892 | 320.5 K to 330.9 K (+3.24 %) |
| Jan 07 2020 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Gift | G | 0.00 | 5,457 | 0 | 64,957 | 70.4 K to 65 K (-7.75 %) |
| Jan 07 2020 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Payment of Exercise | F | 0.00 | 2,494 | 0 | 70,414 | 72.9 K to 70.4 K (-3.42 %) |
| Jan 07 2020 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Gift | G | 0.00 | 10,398 | 0 | 72,249 | 82.6 K to 72.2 K (-12.58 %) |
| Jan 07 2020 | FLXN | Flexion Therapeuti ... | Willwerth Christina | Chief Strategy Offi ... | Sell | S | 0.00 | 3,533 | 0 | 52,473 | 56 K to 52.5 K (-6.31 %) |
| Jan 07 2020 | FLXN | Flexion Therapeuti ... | KELLEY SCOTT | Chief Medical Offic ... | Sell | S | 0.00 | 3,724 | 0 | 49,365 | 53.1 K to 49.4 K (-7.01 %) |
| Jan 07 2020 | FLXN | Flexion Therapeuti ... | Willwerth Christina | Chief Strategy Offi ... | Sell | S | 0.00 | 3,533 | 0 | 52,473 | 56 K to 52.5 K (-6.31 %) |
| Jan 07 2020 | FLXN | Flexion Therapeuti ... | KELLEY SCOTT | Chief Medical Offic ... | Sell | S | 0.00 | 3,724 | 0 | 49,365 | 53.1 K to 49.4 K (-7.01 %) |
| Jan 07 2020 | FLXN | Flexion Therapeuti ... | Levine Mark S. | General Counsel | Sell | S | 0.00 | 3,724 | 0 | 43,487 | 47.2 K to 43.5 K (-7.89 %) |
| Jan 07 2020 | FLXN | Flexion Therapeuti ... | Wentworth Kerry | Chief Regulatory Of ... | Sell | S | 0.00 | 3,724 | 0 | 50,061 | 53.8 K to 50.1 K (-6.92 %) |
| Jan 07 2020 | FLXN | Flexion Therapeuti ... | Arkowitz David | Chief Financial Off ... | Sell | S | 0.00 | 3,095 | 0 | 88,481 | 91.6 K to 88.5 K (-3.38 %) |
| Jan 07 2020 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Scientific Of ... | Sell | S | 0.00 | 3,851 | 0 | 100,153 | 104 K to 100.2 K (-3.70 %) |
| Oct 08 2019 | FLXN | Flexion Therapeuti ... | Willwerth Christina | Chief Strategy Offi ... | Payment of Exercise | F | 13.98 | 1,002 | 14,008 | 66,167 | 67.2 K to 66.2 K (-1.49 %) |
| Oct 08 2019 | FLXN | Flexion Therapeuti ... | Wentworth Kerry | Chief Regulatory Of ... | Option Exercise | M | 0.00 | 3,400 | 0 | 0 | |
| Oct 08 2019 | FLXN | Flexion Therapeuti ... | Wentworth Kerry | Chief Regulatory Of ... | Payment of Exercise | F | 13.98 | 1,002 | 14,008 | 53,394 | 54.4 K to 53.4 K (-1.84 %) |
| Oct 08 2019 | FLXN | Flexion Therapeuti ... | Wentworth Kerry | Chief Regulatory Of ... | Buy | M | 0.00 | 3,400 | 0 | 54,396 | 51 K to 54.4 K (+6.67 %) |
| Oct 08 2019 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Option Exercise | M | 0.00 | 14,800 | 0 | 0 | |
| Oct 08 2019 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Payment of Exercise | F | 13.98 | 4,402 | 61,540 | 82,647 | 87 K to 82.6 K (-5.06 %) |
| Oct 08 2019 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Buy | M | 0.00 | 14,800 | 0 | 87,049 | 72.2 K to 87 K (+20.48 %) |
| Oct 08 2019 | FLXN | Flexion Therapeuti ... | KELLEY SCOTT | Chief Medical Offic ... | Payment of Exercise | F | 13.98 | 334 | 4,669 | 53,089 | 53.4 K to 53.1 K (-0.63 %) |
| Oct 08 2019 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Scientific Of ... | Option Exercise | M | 0.00 | 4,568 | 0 | 0 | |
| Oct 08 2019 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Scientific Of ... | Payment of Exercise | F | 13.98 | 1,346 | 18,817 | 104,004 | 105.4 K to 104 K (-1.28 %) |
| Oct 08 2019 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Scientific Of ... | Buy | M | 0.00 | 4,568 | 0 | 105,350 | 100.8 K to 105.4 K (+4.53 %) |
| Aug 29 2019 | FLXN | Flexion Therapeuti ... | MAHAFFY PATRICK J | Director | Option Exercise | M | 0.16 | 30,824 | 4,932 | 0 | |
| Aug 29 2019 | FLXN | Flexion Therapeuti ... | MAHAFFY PATRICK J | Director | Option Exercise | M | 0.16 | 30,824 | 4,932 | 0 | |
| Aug 29 2019 | FLXN | Flexion Therapeuti ... | MAHAFFY PATRICK J | Director | Buy | M | 0.16 | 30,824 | 4,932 | 30,824 | 0 to 30.8 K |
| Aug 29 2019 | FLXN | Flexion Therapeuti ... | MAHAFFY PATRICK J | Director | Buy | M | 0.16 | 30,824 | 4,932 | 30,824 | 0 to 30.8 K |
| Aug 14 2019 | FLXN | Flexion Therapeuti ... | Willwerth Christina | Chief Strategy Offi ... | Option Exercise | M | 0.16 | 8,750 | 1,400 | 0 | |
| Aug 14 2019 | FLXN | Flexion Therapeuti ... | Willwerth Christina | Chief Strategy Offi ... | Buy | M | 0.16 | 8,750 | 1,400 | 67,169 | 58.4 K to 67.2 K (+14.98 %) |
| Aug 09 2019 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Buy | P | 10.74 | 2,000 | 21,480 | 45,333 | 43.3 K to 45.3 K (+4.62 %) |
| Aug 08 2019 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Buy | P | 10.85 | 2,317 | 25,136 | 72,249 | 69.9 K to 72.2 K (+3.31 %) |
| Jun 24 2019 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Gift | G | 0.00 | 1,492 | 0 | 320,494 | 319 K to 320.5 K (+0.47 %) |
| Jun 24 2019 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Gift | G | 0.00 | 4,936 | 0 | 319,002 | 314.1 K to 319 K (+1.57 %) |
| Jun 24 2019 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Gift | G | 0.00 | 1,492 | 0 | 69,932 | 71.4 K to 69.9 K (-2.09 %) |
| Jun 24 2019 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Grant | A | 9.81 | 1,492 | 14,637 | 71,424 | 69.9 K to 71.4 K (+2.13 %) |
| Jun 24 2019 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Gift | G | 0.00 | 4,936 | 0 | 69,932 | 74.9 K to 69.9 K (-6.59 %) |
| Jun 24 2019 | FLXN | Flexion Therapeuti ... | Levine Mark S. | General Counsel | Grant | A | 9.81 | 1,213 | 11,900 | 46,273 | 45.1 K to 46.3 K (+2.69 %) |
| Jun 24 2019 | FLXN | Flexion Therapeuti ... | Wentworth Kerry | Chief Regulatory Of ... | Grant | A | 9.81 | 389 | 3,816 | 50,996 | 50.6 K to 51 K (+0.77 %) |
| Jun 24 2019 | FLXN | Flexion Therapeuti ... | KELLEY SCOTT | Chief Medical Offic ... | Grant | A | 9.81 | 2,152 | 21,111 | 53,423 | 51.3 K to 53.4 K (+4.20 %) |
| Jun 24 2019 | FLXN | Flexion Therapeuti ... | Arkowitz David | Chief Financial Off ... | Grant | A | 9.81 | 2,152 | 21,111 | 91,576 | 89.4 K to 91.6 K (+2.41 %) |
| Jun 21 2019 | FLXN | Flexion Therapeuti ... | Stejbach Mark | Director | Option Exercise | A | 11.74 | 12,500 | 146,750 | 12,500 | |
| Jun 21 2019 | FLXN | Flexion Therapeuti ... | MILINAZZO ALAN | Director | Option Exercise | A | 11.74 | 12,500 | 146,750 | 12,500 | |
| Jun 21 2019 | FLXN | Flexion Therapeuti ... | MERRIFIELD C ANN | Director | Option Exercise | A | 11.74 | 12,500 | 146,750 | 12,500 | |
| Jun 21 2019 | FLXN | Flexion Therapeuti ... | Mahatme Sandesh | Director | Option Exercise | A | 11.74 | 12,500 | 146,750 | 12,500 | |
| Jun 21 2019 | FLXN | Flexion Therapeuti ... | COLELLA SAMUEL D | Director | Option Exercise | A | 11.74 | 12,500 | 146,750 | 12,500 | |
| Jun 21 2019 | FLXN | Flexion Therapeuti ... | Canute Scott A | Director | Option Exercise | A | 11.74 | 12,500 | 146,750 | 12,500 | |
| Jun 21 2019 | FLXN | Flexion Therapeuti ... | MAHAFFY PATRICK J | Director | Option Exercise | A | 11.74 | 18,000 | 211,320 | 18,000 | |
| Jun 03 2019 | FLXN | Flexion Therapeuti ... | Arkowitz David | Chief Financial Off ... | Buy | P | 11.05 | 2,500 | 27,627 | 89,424 | 86.9 K to 89.4 K (+2.88 %) |
| May 24 2019 | FLXN | Flexion Therapeuti ... | MERRIFIELD C ANN | Director | Buy | P | 12.64 | 8,000 | 101,120 | 10,000 | 2 K to 10 K (+400.00 %) |
| May 15 2019 | FLXN | Flexion Therapeuti ... | Arkowitz David | Chief Financial Off ... | Buy | P | 11.99 | 4,000 | 47,960 | 86,924 | 82.9 K to 86.9 K (+4.82 %) |
| May 13 2019 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Buy | P | 12.48 | 4,012 | 50,067 | 74,868 | 70.9 K to 74.9 K (+5.66 %) |
| May 09 2019 | FLXN | Flexion Therapeuti ... | Arkowitz David | Chief Financial Off ... | Sell | S | 10.06 | 2,248 | 22,615 | 82,924 | 85.2 K to 82.9 K (-2.64 %) |
| Mar 13 2019 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Buy | P | 12.36 | 4,046 | 50,009 | 70,856 | 66.8 K to 70.9 K (+6.06 %) |
| Mar 05 2019 | FLXN | Flexion Therapeuti ... | KELLEY SCOTT | Chief Medical Offic ... | Option Exercise | A | 14.75 | 18,000 | 265,500 | 18,000 | |
| Mar 05 2019 | FLXN | Flexion Therapeuti ... | KELLEY SCOTT | Chief Medical Offic ... | Grant | A | 0.00 | 36,000 | 0 | 51,271 | 15.3 K to 51.3 K (+235.74 %) |
| Mar 05 2019 | FLXN | Flexion Therapeuti ... | Willwerth Christina | Chief Strategy Offi ... | Option Exercise | A | 14.75 | 18,000 | 265,500 | 18,000 | |
| Mar 05 2019 | FLXN | Flexion Therapeuti ... | Willwerth Christina | Chief Strategy Offi ... | Grant | A | 0.00 | 36,000 | 0 | 58,419 | 22.4 K to 58.4 K (+160.58 %) |
| Mar 05 2019 | FLXN | Flexion Therapeuti ... | Levine Mark S. | General Counsel | Option Exercise | A | 14.75 | 18,000 | 265,500 | 18,000 | |
| Mar 05 2019 | FLXN | Flexion Therapeuti ... | Levine Mark S. | General Counsel | Grant | A | 0.00 | 36,000 | 0 | 45,060 | 9.1 K to 45.1 K (+397.35 %) |
| Mar 05 2019 | FLXN | Flexion Therapeuti ... | Arkowitz David | Chief Financial Off ... | Option Exercise | A | 14.75 | 18,000 | 265,500 | 18,000 | |
| Mar 05 2019 | FLXN | Flexion Therapeuti ... | Arkowitz David | Chief Financial Off ... | Grant | A | 0.00 | 36,000 | 0 | 85,172 | 49.2 K to 85.2 K (+73.21 %) |
| Mar 05 2019 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Scientific Of ... | Option Exercise | A | 14.75 | 18,000 | 265,500 | 18,000 | |
| Mar 05 2019 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Scientific Of ... | Grant | A | 0.00 | 36,000 | 0 | 100,782 | 64.8 K to 100.8 K (+55.57 %) |
| Jan 04 2019 | FLXN | Flexion Therapeuti ... | Levine Mark S. | General Counsel | Sell | S | 12.36 | 734 | 9,072 | 9,060 | 9.8 K to 9.1 K (-7.49 %) |
| Jan 04 2019 | FLXN | Flexion Therapeuti ... | Wentworth Kerry | Chief Regulatory Of ... | Sell | S | 12.36 | 622 | 7,688 | 11,207 | 11.8 K to 11.2 K (-5.26 %) |
| Jan 04 2019 | FLXN | Flexion Therapeuti ... | KELLEY SCOTT | Chief Medical Offic ... | Sell | S | 12.36 | 622 | 7,688 | 15,271 | 15.9 K to 15.3 K (-3.91 %) |
| Jan 04 2019 | FLXN | Flexion Therapeuti ... | Arkowitz David | Chief Financial Off ... | Buy | J | 10.48 | 922 | 9,663 | 49,172 | 48.3 K to 49.2 K (+1.91 %) |
| Jan 04 2019 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Scientific Of ... | Sell | S | 12.36 | 746 | 9,221 | 64,782 | 65.5 K to 64.8 K (-1.14 %) |
| Nov 13 2018 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Gift | G | 0.00 | 8,567 | 0 | 314,066 | 305.5 K to 314.1 K (+2.80 %) |
| Nov 13 2018 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Gift | G | 0.00 | 10,562 | 0 | 305,499 | 294.9 K to 305.5 K (+3.58 %) |
| Nov 13 2018 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Gift | G | 0.00 | 554 | 0 | 294,937 | 294.4 K to 294.9 K (+0.19 %) |
| Nov 13 2018 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Buy | P | 17.10 | 5,000 | 85,477 | 69,166 | 64.2 K to 69.2 K (+7.79 %) |
| Nov 13 2018 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Gift | G | 0.00 | 8,567 | 0 | 64,166 | 72.7 K to 64.2 K (-11.78 %) |
| Nov 13 2018 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Gift | G | 0.00 | 10,562 | 0 | 72,733 | 83.3 K to 72.7 K (-12.68 %) |
| Nov 13 2018 | FLXN | Flexion Therapeuti ... | Clayman Michael D. | President and CEO | Gift | G | 0.00 | 554 | 0 | 83,295 | 83.8 K to 83.3 K (-0.66 %) |
| Nov 13 2018 | FLXN | Flexion Therapeuti ... | Arkowitz David | Chief Financial Off ... | Buy | P | 16.56 | 4,000 | 66,222 | 48,250 | 44.3 K to 48.3 K (+9.04 %) |
| Oct 09 2018 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Scientific Of ... | Option Exercise | M | 0.00 | 4,566 | 0 | 4,568 | |
| Oct 09 2018 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Scientific Of ... | Payment of Exercise | F | 18.60 | 1,345 | 25,017 | 65,528 | 66.9 K to 65.5 K (-2.01 %) |
| Oct 09 2018 | FLXN | Flexion Therapeuti ... | Bodick Neil | Chief Scientific Of ... | Buy | M | 0.00 | 4,566 | 0 | 66,873 | 62.3 K to 66.9 K (+7.33 %) |